First, the choice of comparator matters: placebo-controlled RCTs estimate how GLP1-RAs perform against no active therapy of that class, whereas our analyses reflect the real clinical choice between drug classes
8 Masking symptoms instead of addressing disease Dinkov suggests the drugs simply reduce visible signs of diabetes while allowing the underlying pathology to progress unchecked
By understanding the science behind GLP-1 drugs and implementing effective strategies, you can navigate your weight loss journey with confidence
Retatrutide is currently in Phase 3 clinical trials through the TRIUMPH program conducted by Eli Lilly
However, a smaller biotechnology firm, Viking Therapeutics, is noted as a potential competitor
While these medications offer significant benefits, they can sometimes come with digestive side effects that affect comfort and well-being